amgen glp 1 agonist A Booming Weight-Loss Drug Discovery Landscape at a Glance Progress on Amgen's Weight Loss

Gastrostomy for venting and/or jejunostomy for feeding may be required for symptom relief

10.1016/j.molmet.2023.101850 55 MosserD

Dual- and triple-receptor agonists also offer the potential for the treatment of obesity (3941)

Delayed gastric emptying was first noted in patients with diabetes and subsequently reported by Boas in 1925

188,208 Although a modest reduction in lean mass was observed at 12 months, muscle function, assessed via handgrip strength, improved significantly, the prevalence of sarcopenic obesity declined, and resting energy expenditure relative to lean mass increasedindicating enhanced metabolic efficiency